{"id":"NCT00622284","sponsor":"Boehringer Ingelheim","briefTitle":"Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes","officialTitle":"A Randomised Double-blind, Active-controlled Parallel Group Efficacy and Safety Study of BI 1356 ( 5.0 mg, Administered Orally Once Daily) Compared to Glimepiride Over Two Years in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2010-12","completion":null,"firstPosted":"2008-02-25","resultsPosted":"2012-02-20","lastUpdate":"2014-01-29"},"enrollment":1560,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Placebo identical to BI 1356 5mg","otherNames":[]},{"type":"DRUG","name":"Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4 mg","otherNames":[]},{"type":"DRUG","name":"BI 1356","otherNames":[]},{"type":"DRUG","name":"Glimepiride","otherNames":[]}],"arms":[{"label":"BI 1356 5mg, once daily","type":"EXPERIMENTAL"},{"label":"Glimepiride","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of the current study is to investigate the efficacy, safety and tolerability of BI 1356 (5.0 mg daily) compared to glimepiride given for 104 weeks as add-on therapy to preferably \\> 1500 mg metformin in patients with type 2 diabetes mellitus with insufficient glycaemic control","primaryOutcome":{"measure":"HbA1c Change From Baseline at Week 52","timeFrame":"Baseline and week 52","effectByArm":[{"arm":"Linagliptin","deltaMin":-0.36,"sd":0.03},{"arm":"Glimepiride","deltaMin":-0.57,"sd":0.03}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0005"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":221,"countries":["United States","Bulgaria","Denmark","France","Germany","Hong Kong","Hungary","India","Ireland","Italy","Netherlands","Norway","Poland","South Africa","Sweden","United Kingdom"]},"refs":{"pmids":["40020703","23521323","22748821","22234149"],"seeAlso":["http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/1218/1218.20_Literature.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":135,"n":776},"commonTop":["Hypoglycaemia","Nasopharyngitis","Back pain","Upper respiratory tract infection","Diarrhoea"]}}